437 related articles for article (PubMed ID: 34493193)
21. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol.
Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS
Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.
Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW
Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289
[TBL] [Abstract][Full Text] [Related]
23. Lights and Shadows in the Use of Mesenchymal Stem Cells in Lung Inflammation, a Poorly Investigated Topic in Cystic Fibrosis.
Caretti A; Peli V; Colombo M; Zulueta A
Cells; 2019 Dec; 9(1):. PubMed ID: 31861724
[TBL] [Abstract][Full Text] [Related]
24. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.
Gupta A; Kashte S; Gupta M; Rodriguez HC; Gautam SS; Kadam S
Hum Cell; 2020 Oct; 33(4):907-918. PubMed ID: 32780299
[TBL] [Abstract][Full Text] [Related]
26. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
[TBL] [Abstract][Full Text] [Related]
27. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.
Fang Y; Lao P; Tang L; Chen J; Chen Y; Sun L; Tan W; Fan X
Cell Transplant; 2023; 32():9636897231184611. PubMed ID: 37395459
[TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicles in the pathogenesis and treatment of acute lung injury.
Hu Q; Zhang S; Yang Y; Yao JQ; Tang WF; Lyon CJ; Hu TY; Wan MH
Mil Med Res; 2022 Nov; 9(1):61. PubMed ID: 36316787
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
Wang W; Lei W; Jiang L; Gao S; Hu S; Zhao ZG; Niu CY; Zhao ZA
J Transl Med; 2021 May; 19(1):198. PubMed ID: 33971907
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome.
Abraham A; Krasnodembskaya A
Stem Cells Transl Med; 2020 Jan; 9(1):28-38. PubMed ID: 31647191
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.
Sadeghi B; Ringdén O; Gustafsson B; Castegren M
Front Immunol; 2022; 13():963445. PubMed ID: 36426365
[TBL] [Abstract][Full Text] [Related]
33. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
Hamdan H; Hashmi SK; Lazarus H; Gale RP; Qu W; El Fakih R
Blood Rev; 2021 Mar; 46():100742. PubMed ID: 32854985
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?
Muraca M; Pessina A; Pozzobon M; Dominici M; Galderisi U; Lazzari L; Parolini O; Lucarelli E; Perilongo G; Baraldi E
J Control Release; 2020 Sep; 325():135-140. PubMed ID: 32622963
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Harrell CR; Jovicic BP; Djonov V; Volarevic V
Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
[TBL] [Abstract][Full Text] [Related]
36. Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis.
Gazzaniga G; Voltini M; Carletti A; Lenta E; Meloni F; Briganti DF; Avanzini MA; Comoli P; Belliato M
Respir Res; 2024 Apr; 25(1):170. PubMed ID: 38637860
[TBL] [Abstract][Full Text] [Related]
37. Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives.
Guo H; Su Y; Deng F
Stem Cell Rev Rep; 2021 Apr; 17(2):440-458. PubMed ID: 33211245
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
[TBL] [Abstract][Full Text] [Related]
39. Specific Clinical and Immunological Changes Following Mesenchymal Stem Cell Transplantation in COVID-19-induced Acute Respiratory Distress Syndrome Patients: A Phase-I Clinical Trial.
Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Nikpoor AR; Tavakol Afshari J
Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):687-703. PubMed ID: 36640060
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
Front Immunol; 2018; 9():2837. PubMed ID: 30564236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
